Bitcoin’s Worst Crash Years: Implications for 2026 Investors
Six years after Bitcoin endured its COVID-era collapse, the market has staged a dramatic rebound. This piece examines...
Understanding when to pay capital gains on airdrops helps you align reporting with disposition events and IRS rules in 2026.
26,521 articlesSix years after Bitcoin endured its COVID-era collapse, the market has staged a dramatic rebound. This piece examines...
A triple-leveraged note tied to a tech stock basket plunged 18% in a single session, erasing much of a year’s gains a...
China’s DeepSeek AI forecasts notable upside for XRP, PEPE, and Shiba Inu through 2026, highlighting potential cataly...
The 2026 Social Security COLA is 2.8%, but higher-income retirees face loss due to Medicare IRMAA surcharges that swa...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
REMAX Select reports a sharp rise in transaction sides driven by collaboration across markets, earning a top-10 place...
A retiree inherits a traditional IRA and sees Medicare premiums rise in 2026 due to a 2024 income spike, exposing the...
A smaller biotech is stealing headlines in 2026 by delivering strong trial results and strategic collaborations. This...
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Gold has emerged as a standout performer in 2026, with certain bullion-backed ETFs delivering resilience and steady g...
In 2026, a disciplined trio of growth ETFs offers a clear path to long-term wealth through earnings-driven expansion,...